• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Cardiology

Body weight may not be the best way to assess cardiometabolic risk in some minority populations

byDeepti Shroff KarhadeandCaitlyn Hui
April 4, 2017
in Cardiology, Chronic Disease, Endocrinology, Public Health
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. All racial/ethnic minority groups evaluated, compared with Caucasian patients, had a statistically higher prevalence of metabolic abnormality but normal body weight (MAN).

2. Using BMI as a method of screening for increased cardiometabolic risk may leave out a significant proportion of vulnerable patients.

Evidence Rating Level: Good (2)

Study Rundown: Body weight is a common method used to screen for cardiometabolic disease, as overweight and obesity are well-known risk factors. However, patients with a healthy weight may also have increased cardiometabolic risk. It has been suggested that the relationship between obesity and cardiometabolic abnormalities may vary among ethnic groups. The authors of this study aimed to determine the prevalence and correlates of the phenotype of metabolic abnormality but normal weight (MAN) for 5 racial/ethnic groups. In general, they observed that minority groups had a higher prevalence of MAN. This study has several limitations. Specifically, there are differences in timing of data collection between studies used, which may have resulted in differences in the prevalence of overweight and obesity between the 2 cohorts. Overall, this study suggests that an alternative-screening tool for cardiometabolic risk may be more appropriate in order to avoid missing patients with normal body weights but increased risk.

Click to read the study, published today in the Annals of Internal Medicine

Relevant Reading: Ethnic Group Differences in Cardiometabolic Disease Risk Factors Independent of Body Mass Index among American Youth

RELATED REPORTS

Mazdutide significantly reduces weight in adults with overweight or obesity

Body mass index-specific waist circumference thresholds may improve mortality risk stratification in women

Tirzepatide-associated improvements in cardiometabolic risk factors linked to degree of weight loss

In-Depth [retrospective cohort]: The authors of this study conducted a cross-sectional analysis using 2 community-based cohorts, MESA (Multi-Ethnic Study of Atherosclerosis) and the MASALA (Mediators of Atherosclerosis in South Asians Living in America). Statistics were calculated using pooled data from the two cohorts. In general, there was an increased prevalence of MAN in all 5 racial/ethnic groups compared to white patients. Specifically, the prevalence of MAN was 21.0% (95% CI, 18.4%-23.9%) in whites, 32,2% (CI, 27.3% to 37.4%) in Chinese Americans, 31.1% (CI, 26.3% to 36.3%) in African Americans, 38.5% (CI, 32.6% to 44.6%) in Hispanics, and 43.6% (CI, 36.8% to 50.6%) in South Asians.

Image: PD

©2017 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: ethnicityobesityoverweight
Previous Post

Tdap vaccination in pregnancy effective in preventing pertussis in infants

Next Post

Being overweight at any point in adulthood increases risk for death

RelatedReports

Increasing maternal BMI linked to higher risk of cerebral palsy
Cardiology

Mazdutide significantly reduces weight in adults with overweight or obesity

July 11, 2025
Majority of obese tenth-graders already obese by fifth grade
Chronic Disease

Body mass index-specific waist circumference thresholds may improve mortality risk stratification in women

July 7, 2025
Sleep duration inversely related to childhood type 2 diabetes risk makers
Cardiology

Tirzepatide-associated improvements in cardiometabolic risk factors linked to degree of weight loss

June 23, 2025
#VisualAbstract: Once-Weekly Mazdutide Reduced Body Weight in Obese or Overweight Chinese Adults
StudyGraphics

#VisualAbstract: Once-Weekly Mazdutide Reduced Body Weight in Obese or Overweight Chinese Adults

June 16, 2025
Next Post
FDA-approved weight loss medications associated with weight loss at one year

Being overweight at any point in adulthood increases risk for death

Smoking during pregnancy associated with aerobic fitness of children

2 Minute Medicine Rewind April 3, 2017

Adding daratumumab increases progression free survival in multiple myeloma

Multiple myeloma management with lenalidomide, bortezomib and dexamethasone associated with prolonged progression-free survival

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Living in a marginalized neighbourhood is associated with worse outcomes in patients with myocardial infarction
  • SGLT2 inhibitors may delay cognitive impairment in elderly patients with heart failure
  • Nerandomilast slows decline in FVC in idiopathic pulmonary fibrosis
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.